Articles Written by:    SARAH RUBENSTEIN     

« Previous  |  Next »

Envelopes with Unknown Powder Found at Wall Street Journal

WSJ Health Blog HQ is locked down after a dozen envelopes addressed to various people at The Wall Street Journal containing unknown powder were found. Normally we would go for a stroll around the World Financial Center to stretch our legs during lunch, ...

From SARAH RUBENSTEIN, Wall Street Journal,  21 Jan 2009
Related Topics: Wall Street Journal,  Dow Jones

Will Obama Build on Bush Legacy in Community Health?

WSJ.com is available in the following editions and languages: Thank you for registering. We sent an email to: Please click on the link inside the email to complete your registration Please register to gain free access to WSJ tools. An account already ...

From SARAH RUBENSTEIN, Wall Street Journal,  21 Jan 2009
Related Topics: Barack Obama,  Wall Street Journal,  U.S. Congress,  George W. Bush

Diversified Abbott Outshines Diversified Johnson & Johnson

WSJ’s blog on health and the business of health. After Johnson & Johnson’s gloomy earnings report yesterday, we were intrigued by Abbott’s cheerier results this morning. Abbott has been following J&J’s lead in building a diversified health-care ...

From SARAH RUBENSTEIN, Wall Street Journal,  21 Jan 2009
Related Topics: Johnson & Johnson,  Dow Jones,  Wall Street Journal

Chilled Inaugural Crowds Visit Medical Tents

WSJ’s blog on health and the business of health. It was cold out there yesterday. Nurse Tammie Brent spends most of her time at the FDA reviewing the pregnancy and lactation sections of drug labels. Yesterday, she was among the medical pros helping ...

From SARAH RUBENSTEIN, Wall Street Journal,  21 Jan 2009
Related Topics: Food and Drug Administration,  Barack Obama,  Wall Street Journal

E-Prescribing: Green Means Generic; Red Means Pricey Brand

WSJ’s blog on health and the business of health. Most doctors still use pen and pad to write prescriptions, but the ranks doing it electronically are growing as the feds pressure docs to make the switch. The number of docs who prescribe by computer ...

From SARAH RUBENSTEIN, Wall Street Journal,  21 Jan 2009
Related Topics: Wall Street Journal

After Seizure, Ted Kennedy Leaves Inaugural Luncheon in Ambulance

WSJ’s blog on health and the business of health. Kennedy arrives at the Capitol earlier today. Ted Kennedy collapsed during an inaugural lunch with President Barack Obama and congressional leaders and was taken away in an ambulance. “It looked like ...

From SARAH RUBENSTEIN, Wall Street Journal,  20 Jan 2009
Related Topics: Ted Kennedy (politician),  Orrin Hatch,  Barack Obama,  Walter Mondale,  MSNBC

Should a Health Fed Decide if a Drug Is Worth the Cost?

WSJ’s blog on health and the business of health. Scott Gottlieb, who served in the FDA and CMS under the last president, lands on the op-ed pages of today’s WSJ arguing against President Obama and House Democrats’ efforts to go down this road. “They ...

From SARAH RUBENSTEIN, Wall Street Journal,  20 Jan 2009
Related Topics: Food and Drug Administration,  Barack Obama,  U.S. Democratic Party,  American Enterprise Institute,  Wall Street Journal

Obama: Health Care Costs Too Much, but Technology Can Help

We, focused as ever, listened for any tidbits about health care and heard two. First, there was an acknowledgment of the expense of health care in a long list of woes the nation now faces. That we are in the midst of crisis is now well understood. Our ...

From SARAH RUBENSTEIN, Wall Street Journal,  20 Jan 2009
Related Topics: Barack Obama

Steven Nissen Gives Obama an Rx for FDA Reform

WSJ’s blog on health and the business of health. Is the crowd buzzing in anticipation of changes at the FDA? Barack Obama most definitely doesn’t have time to read the journal Nature right now. But maybe can spare a minute for a quick read of the ...

From SARAH RUBENSTEIN, Wall Street Journal,  20 Jan 2009
Related Topics: Food and Drug Administration,  Barack Obama,  Wall Street Journal

An Old Drug Called Salsalate Could Become Cheap Diabetes Fighter

WSJ’s blog on health and the business of health. Over the past couple of years we’ve been hearing a lot about fancy brand-name drugs for diabetes, like Merck’s Januvia or GlaxoSmithKline’s Avandia. But could the real breakthrough be salsalate, a ...

From SARAH RUBENSTEIN, Wall Street Journal,  20 Jan 2009
Related Topics: Merck & Company, Inc.,  GlaxoSmithKline Inc,  Harvard University,  National Institutes of Health,  Wall Street Journal

« Previous  |  Next »

Who is This?

Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.

Suggest an Entry

Enter a url from sourcewatch.org or wikipedia.org:


recommend removal

close